Effectiveness of BNCT for recurrent head and neck malignancies I Kato, K Ono, Y Sakurai, M Ohmae, A Maruhashi, Y Imahori, M Kirihata, ... Applied Radiation and Isotopes 61 (5), 1069-1073, 2004 | 368 | 2004 |
Survival benefit of boron neutron capture therapy for recurrent malignant gliomas SI Miyatake, S Kawabata, K Yokoyama, T Kuroiwa, H Michiue, Y Sakurai, ... Journal of neuro-oncology 91, 199-206, 2009 | 175 | 2009 |
Boron neutron capture therapy for newly diagnosed glioblastoma S Kawabata, SI Miyatake, T Kuroiwa, K Yokoyama, A Doi, K Iida, S Miyata, ... Journal of radiation research 50 (1), 51-60, 2009 | 148 | 2009 |
Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy … SI Miyatake, S Kawabata, Y Kajimoto, A Aoki, K Yokoyama, M Yamada, ... Journal of neurosurgery 103 (6), 1000-1009, 2005 | 148 | 2005 |
Effectiveness of boron neutron capture therapy for recurrent head and neck malignancies I Kato, Y Fujita, A Maruhashi, H Kumada, M Ohmae, M Kirihata, Y Imahori, ... Applied Radiation and Isotopes 67 (7-8), S37-S42, 2009 | 142 | 2009 |
Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His B Feng, K Tomizawa, H Michiue, S Miyatake, XJ Han, A Fujimura, M Seno, ... Biomaterials 30 (9), 1746-1755, 2009 | 126 | 2009 |
Proline Catalyzes Direct C–H Arylations of Unactivated Arenes K Tanimoro, M Ueno, K Takeda, M Kirihata, S Tanimori The Journal of organic chemistry 77 (18), 7844-7849, 2012 | 119 | 2012 |
Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy A Doi, S Kawabata, K Iida, K Yokoyama, Y Kajimoto, T Kuroiwa, ... Journal of neuro-oncology 87, 287-294, 2008 | 116 | 2008 |
Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT K Yokoyama, SI Miyatake, Y Kajimoto, S Kawabata, A Doi, T Yoshida, ... Journal of Neuro-oncology 78, 227-232, 2006 | 92 | 2006 |
Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients S Kawabata, SI Miyatake, N Nonoguchi, R Hiramatsu, K Iida, S Miyata, ... Applied Radiation and Isotopes 67 (7-8), S15-S18, 2009 | 90 | 2009 |
Synthesis of novel quinoxaline derivatives and its cytotoxic activities S Tanimori, T Nishimura, M Kirihata Bioorganic & medicinal chemistry letters 19 (15), 4119-4121, 2009 | 71 | 2009 |
The early successful treatment of glioblastoma patients with modified boron neutron capture therapy S Kawabata, SI Miyatake, Y Kajimoto, Y Kuroda, T Kuroiwa, Y Imahori, ... Journal of neuro-oncology 65, 159-165, 2003 | 68 | 2003 |
Biological Evaluation of Dodecaborate-Containing l-Amino Acids for Boron Neutron Capture Therapy Y Hattori, S Kusaka, M Mukumoto, K Uehara, T Asano, M Suzuki, ... Journal of Medicinal Chemistry 55 (15), 6980-6984, 2012 | 67 | 2012 |
Phase II clinical study of boron neutron capture therapy combined with X-ray radiotherapy/temozolomide in patients with newly diagnosed glioblastoma multiforme—Study design … S Kawabata, SI Miyatake, R Hiramatsu, Y Hirota, S Miyata, Y Takekita, ... Applied Radiation and Isotopes 69 (12), 1796-1799, 2011 | 60 | 2011 |
Evaluation of fluoride-labeled boronophenylalanine-PET imaging for the study of radiation effects in patients with glioblastomas M Miyashita, SI Miyatake, Y Imahori, K Yokoyama, S Kawabata, ... Journal of neuro-oncology 89, 239-246, 2008 | 58 | 2008 |
Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma G Futamura, S Kawabata, N Nonoguchi, R Hiramatsu, T Toho, H Tanaka, ... Radiation Oncology 12, 1-11, 2017 | 57 | 2017 |
Intracellular target delivery of cell-penetrating peptide-conjugated dodecaborate for boron neutron capture therapy (BNCT) I Nakase, M Katayama, Y Hattori, M Ishimura, S Inaura, D Fujiwara, ... Chemical Communications 55 (93), 13955-13958, 2019 | 54 | 2019 |
Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: A validation study for the theranostic approach using [18 F]-L-FBPA … T Watanabe, Y Hattori, Y Ohta, M Ishimura, Y Nakagawa, Y Sanada, ... BMC cancer 16, 1-10, 2016 | 54 | 2016 |
A General and Practical Access to Chiral Quinoxalinones with Low Copper‐Catalyst Loading S Tanimori, H Kashiwagi, T Nishimura, M Kirihata Advanced Synthesis & Catalysis 352 (14‐15), 2531-2537, 2010 | 50 | 2010 |
Copper‐Catalyzed Synthesis of 2, 3‐Disubstituted Indoles S Tanimori, H Ura, M Kirihata European journal of organic chemistry 2007 (24), 3977-3980, 2007 | 49 | 2007 |